JP2013081470A - Bottled beverage comprising cap containing supplement and bottle filled with dispersion medium for supplement - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a new bottled beverage wherein a stable granular supplement comprising a plurality of components is stored in a cap, and a bottle is filled with a solution suitable for dispersing the granules.SOLUTION: The beverage is characterized in that a granular which comprises incompatible drugs or nutrients and wherein the surface of the granules is coated with a polyglycerol fatty acid ester is stored in the bottle cap and that the bottle is filled with a solution having a viscosity of 10-300 Pa s measured at a shear deformation rate of 0.01 s-1.

Description

  The present invention relates to a bottled beverage comprising a granular supplement and a bottle filled with a dispersion medium of the supplement.

Supplements, which are nutritional supplements, are attracting attention and are in widespread use. Common supplement dosage forms include tablets, soft capsules, and hard capsules. The dosage form differs depending on the nature of the supplement, such as water solubility and oil solubility, and the character such as odor. Conventionally, the dosage form is a composition formulated based on a set formulation. Many people use multiple types of supplements. In addition, there is a need for a prescription tailored to each individual by changing the component ratio according to the user regardless of the existing prescription amount. When a dry powder is formulated and packaged, it may not disperse in water or may adhere to a cup or the like.
Many attempts have been made to devise solutions to dissolve insoluble drugs. For example, in Patent Document 1, regarding minerals such as magnesium and calcium, Mg salts such as MgCl ₂ (magnesium chloride) or MgSO ₄ (magnesium sulfate) and Ca salts such as CaCl ₂ (calcium chloride) are readily soluble in water. However, while there was a problem that the bitterness was strong, magnesium hydroxide and calcium carbonate, which are hardly soluble in water, were dissolved using a dispersion medium consisting of water, citric acid, and glycine. It has been disclosed that a mineral-containing solution having no bitterness and stable can be provided.

Moreover, although the device on the formulation for taking in a several active ingredient simultaneously is made | formed, it is pointed out that the so-called combination contraindication problems, such as browning and coagulation | solidification, generate | occur | produce by the interaction of a several component. As a method for producing a granule containing a contraindicated drug or a nutritional component, there is a method in which two or more types of granules containing a contraindicated drug are separately produced and then mixed in order to prevent a change in the formulation. Furthermore, an additive may be coated on the surface of the granule to prevent a change in formulation due to contact between the granules and to suppress the bitterness of the drug itself (hereinafter, the additive is coated in this specification). The previous granule is referred to as “original granule”, and a granule prepared by mixing two or more contraindicated drugs or nutritional components may be referred to as “mixed granule”). In the case of producing a mixed granule coated with an additive, conventionally, in order to prevent a change in formulation, each of the coated granules is mixed after the additive is coated on each original granule.

Patent Document 2 discloses a method for producing a mixed granule of isopropylantipyrine (IPA) and acetaminophen, which is a contraindicated drug for IPA. In Patent Document 2, an original granule in which a masking agent is blended with IPA and an original granule in which acetaminophen is blended are mixed to form a mixed granule.
Patent Document 3 discloses a method in which a raw granule is once individually prepared and then coated in a mixed fluidized bed.
That is, as shown in these patent documents, conventionally, it has been considered that the denaturation of a contraindicated drug can be suppressed by coating the surface of an original granule with an additive. However, it has already been found that this alone cannot achieve the purpose of suppressing change in formulation. The biggest cause is the moisture derived from the raw materials used in preparing the raw granule or the moisture derived from the granulation process. For this reason, at present, it is a common method that the raw granules are kneaded and granulated and then dried in an apparatus to reduce the water content to about 5% before coating. Then, the mutual contact between the drugs or nutritional components is suppressed by blocking the contact between the drugs by the coating.
In addition, a bottled beverage that makes these granules easy to drink is not provided.

JP 2004-65016 A JP 2001-19639 A JP-A-2005-60276 Special table 2008-529755 gazette

  An object of the present invention is to provide a novel bottled beverage in which a stable granular supplement containing a plurality of components is contained in a lid and a bottle is filled with a solution suitable for dispersing the granules. . Furthermore, it aims at providing the drink which suppressed the unpleasant tastes, such as a nasty taste and a bitter taste, when the said granule is disperse | distributed to a solution.

The present invention has the following configuration.
(1) A granule whose surface is coated with a polyglycerin fatty acid ester is accommodated in a lid of the bottle, and the bottle has a viscosity of 10 to 300 Pa at a shear deformation rate of 0.01 s ^−1. -The bottled drink characterized by being filled with the solution which is s, and mixing a granule with a solution before drinking, and using for drinking.
(2) A granule containing drugs or nutritional components that are contraindicated in each other, the granule formed by coating the surface of the granule with a polyglycerin fatty acid ester is accommodated in the lid of the bottle, Is filled with a solution having a viscosity of 10 to 300 Pa · s at a shear deformation rate of 0.01 s ⁻¹ , and is used for drinking after mixing granules with the solution before drinking. Entered beverage.
(3) The bottled beverage according to (1) or (2), wherein the solution is an aqueous solution containing gellan gum.
(4) The bottled beverage according to (1) or (2), wherein the solution is an aqueous solution containing psyllium seed gum and / or pectin and gellan gum.
(5) The bottled beverage according to (1) to (4), wherein the water content of the granule is 2% by mass or less.

The storage stability of the granule is high even if it contains a plurality of components, and this granule supplement is built in the lid, so that it can be taken easily. In addition, it can be uniformly dispersed in the solution, and when the container is tilted and poured out, there is little residue in the container, so that the necessary amount of granules can be easily taken. In the case of a solution, a granule such as a supplement whose storage stability is reduced or a supplement prescribed for each person can be mixed with the dispersion medium of the present invention and taken immediately before drinking.
Furthermore, the beverage according to the present invention can maintain the stability of the supplement component for a long period of time, unlike the case where the supplement component is previously dissolved and dispersed in the solution.
Moreover, when the thing which disperse | distributed the granule in the solution is drunk, since a supplement is not melt | dissolving, an unpleasant taste and unpleasant taste are not felt.

The figure which observed the dispersion state of the granule supplement disperse | distributed to the drink. The graph which shows the relationship between the shear rate of a dispersion medium, and a viscosity. The figure which comparatively observed the state which the vitamin B by the presence or absence of the coating by polyglyceryl fatty acid ester melt | dissolves in a drink. An example of a container. The figure which shows the drink of this invention of the state which mixed the granule and the dispersion medium. The figure which shows the 2nd test result which observed the mixing state of a granule and a drink.

  As the drug or nutritional component used in the granule of the present invention, two or more types of incompatible drugs or nutritional components can be used. Combinations of contraindicated drugs or nutritional components include, for example, γ-aminobutyric acid and vitamin C, ginseng and eicosapentaenoic acid-containing seamless capsules, eicosapentaenoic acid-containing seamless capsules and vitamin C, ginseng and gelatin film Examples thereof include a seamless encapsulating agent, a seamless encapsulating agent having vitamin C and a gelatin film, or a metal salt and eicosapentaenoic acid-containing seamless encapsulating agent. In addition, the granule of this invention can also contain a various drug and a nutrient component, The kind is not restrict | limited.

In addition to drugs or nutritional components, the original granule can contain pharmaceutically acceptable additives such as excipients, binders, and disintegrants. As the excipient, those known in the art can be widely used. For example, lactose, sucrose, glucose, D-mannitol, powdered reduced maltose starch syrup, maltitol, xylitol, erythritol, D-sorbitol, Maltose, starch and starch derivatives, aspartame, glycyrrhizic acid and salts thereof, saccharin and salts thereof, stevia and salts thereof, sucralose, acesulfame potassium, calcium hydrogen phosphate and the like, among which lactose, sucrose, D-mannitol, Starch is preferred. These excipients can be used alone or in combination of two or more.

  A wide variety of binders known in the art can be used, such as hydroxypropylcellulose, hydroxypropylmethylcellulose, polyvinylpyrrolidone, methylcellulose, dextrin, starch and starch derivatives, guar gum, gum arabic, tragacanth, alginic acid. And salts thereof, pullulan, carrageenan, gelatin, agar, carboxyvinyl polymer, carmellose sodium and the like, among which hydroxypropylcellulose, hydroxypropylmethylcellulose, polyvinylpyrrolidone and methylcellulose are preferable. These binders can be used alone or in combination of two or more.

  As the disintegrating agent, those widely known in the art can be used, and examples thereof include sodium carboxymethyl starch, carmellose sodium, and low-substituted hydroxypropylcellulose. These disintegrants can be used alone or in combination of two or more.

In the present invention, raw granules containing drugs or nutritional ingredients that are contraindicated with each other, preferably the above-mentioned additives, and the like are manufactured separately. In the production of the original granule, each drug or nutritional component can be produced by the same or similar granulation method.
The production method of the original granule is not particularly limited, and a wide variety of methods known in the art can be used. Specifically, extrusion granulation method, rolling granulation method, stirring granulation method, Examples thereof include a fluidized bed granulation method, a rolling fluidization granulation method, and a kneading granulation method. Among these, the kneading granulation method is preferable.

  As a granulator for kneading and granulating, it is preferable to use a granulator using an apparatus equipped with a kneading blade and a crushing blade. Examples of such a granulator include a triaxial kneading granulator provided by Shinagawa Kogyo Co., Ltd. This apparatus is disclosed in the publication of Patent Document 4, and the manufacturing method of the present invention can be carried out based on the method described in this publication. In the present invention, when it is produced using a granulation method using a triaxial kneader, each granule can be granulated at an arbitrary ratio, and not only the production process can be simplified, but each component of the granule is contained homogeneously. Granules can be prepared and are preferred.

  In the present invention, when two or more kinds of original granules are separately produced for each drug or nutritional component by the same or similar granulation method, incompatible drugs or nutritional components are granulated separately. In this case, each granule may contain other drugs or nutritional components that are not contraindicated.

The bulk density (bulk specific gravity) of the granulated raw granule is not particularly limited, but is preferably 0.35 to 0.75 g / mL, more preferably 0.40 to 0.65 g / mL, 0.5 to 0.63 g / mL is particularly preferred. When the bulk density is less than 0.35 g / mL, the bulk becomes high, and the amount of packaging may increase. On the other hand, when the bulk density exceeds 0.75 g / mL, the bulk is reduced, and a heavy granule is obtained, and the amount of packaging is also reduced. However, it is relatively difficult to prepare granules of 0.75 g / mL or more in consideration of raw material powder properties other than mineral raw materials having a large specific gravity as raw materials. Under such circumstances, when a granule with a large bulk density is added, the bulk density difference between various granules becomes large, causing segregation, which may make it difficult to ensure mixing uniformity of the one-piece granule. .

  The 50% particle size of the original granule is not particularly limited, but is preferably 400 to 700 μm, more preferably 450 to 650 μm, and particularly preferably 500 to 600 μm. If the 50% particle diameter is larger than 700 μm, it becomes difficult to drink, and if it is smaller than 400 μm, the granules may aggregate in the coating.

Next, the obtained raw granules are dried. The drying treatment is preferably performed until the moisture content of the original granule becomes 2% or less. The drying method is not particularly limited, and any method can be adopted as long as it is a drying method used for ordinary granule drying, but the vacuum drying method and the air drying method are preferable. The vacuum drying method and the blast drying method may be carried out independently or in combination. However, it is particularly preferable to use a vacuum drying method because the moisture of the granules can be removed as much as possible. If the water content exceeds 2%, various compounding changes such as accelerated decomposition of incompatible drugs or granules of nutritional components, lowering of the melting point of the drug, color change of the preparation, generation of off-flavor, etc. may occur.

Next, the surface of each dried original granule is coated with a coating agent. As the coating agent, polyglycerin fatty acid ester, shellac, zein, sucrose ester and the like can be used. In this embodiment, coating is performed with a polyglycerol fatty acid ester. In addition, the coating not only suppresses the mixing change of the contraindicated drug or nutritional ingredient granule, but also has the effect of suppressing the elution of the taste of the drug contained in the granule into the beverage. The amount of polyglycerin fatty acid ester for coating is preferably 1 to 1000 parts by mass, more preferably 10 to 100 parts by mass with respect to 100 parts by mass of the original granule, and suppression of weight increase and coating Considering the effect, it is particularly preferable that the amount is about 20 parts by mass.

  As a method of coating the raw granule with polyglycerin fatty acid ester, it is preferable to use the above-described triaxial kneading granulator manufactured by Shinagawa Kogyo. In this case, the apparatus in which the raw granules are prepared can subsequently be used in the coating. In other words, the required amount of polyglycerin fatty acid ester for coating can be added to the apparatus for preparing the original granules, and coating can be performed. In coating, the temperature in the container is preferably set to a temperature near the melting point of the coating agent, and is preferably set to about 55 ° C. near the melting point of the polyglycerol fatty acid ester.

  The bulk density of the granules coated with the polyglycerol fatty acid ester is preferably 0.55 to 0.75 g / mL, and the 50% particle size is preferably 450 to 650 μm. In addition, the standard deviation of the drug or nutrient content in the granule is preferably within 5%, more preferably within 4%, and particularly preferably within 3%.

  The granule obtained in this way may be mixed to prepare a composite granule, but the moisture content of the granule after coating as described above may be 2% or more. Granules mixed with contraindicated drugs and nutritional ingredients may interact quickly, and browning and coagulation may progress. For this reason, it is preferable to perform a drying process again about a granule after coating. The drying of the granule is not particularly limited, but is preferably vacuum drying. When a vacuum drying apparatus is used, it is preferable that the moisture content is 2% or less by performing a drying treatment for 2 to 8 hours.

  Next, the granule of the present invention can be produced by sealing and storing the granule as it is or by mixing the granule as a composite granule in a container lid. The mixing is not particularly limited as long as it is a commonly used mixing apparatus, and any of them can be used. However, when a V-type rotary mixing apparatus is used, a uniform composite granule preparation can be efficiently prepared. This is preferable.

  Even if the granule of the present invention is stored over time, the change does not occur, the appearance hardly changes, and no odor is generated. Specifically, even when stored for a period of 2 months or longer, preferably 4 months or longer, more preferably 6 months or longer, at 40 ° C. and a relative humidity of 75% or higher, there is no change in composition and no change in appearance. .

<Dispersion medium>
The dispersion medium (solution) used in the present invention is a solution having a viscosity of 10 to 300 Pa · s at a shear deformation rate of 0.01 s ⁻¹ (1 / sec). (1) Gellan gum 0.017%, psyllium seed gum 0.45% by weight aqueous solution, (2) Gellan gum 0.025% by weight aqueous solution, (3) Gellan gum 0.04%, pectin 0.0048% by weight aqueous solution Can be provided by adjusting to
A solution having a zero shear viscosity of 45 to 1500 Pa · s, which is a region that behaves as a Newtonian fluid in a region where the shear rate is extremely low, and a viscosity of 10 to 300 Pa · s when the shear rate is 0.01 s ⁻¹ is suitable. Yes.

  Gelling gum, pectin, psyllium seed gum, xanthan gum, locust bean gum, carrageenan, gum arabic, gelatin, starch, dextrin, cellulose, sodium caseinate, glycerin, erythritol, etc. Sugar alcohols.

<Form>
A combination of the above-described dispersion medium and granules stored in a container can be provided.
A dispersion medium packed in a container such as a PET bottle and a granule supplement stored in a lid are used as a set, and the granule supplement is mixed with the dispersion medium when used. The granule supplement may be packaged and stored in a lid with a small storage unit. A dispersion medium such as a gelling agent is subjected to a treatment such as warming, stirring and dissolving, and filled in a container in a solution state.
For example, a bottle provided with a known cap with a storage portion can be used. Granules are stored in the cap storage portion, the dispersion medium of the present invention is stored in the bottle container body, and the granules in the cap are mixed with the dispersion medium just before taking and can be used for drinking.
FIG. 4 shows an example of a beverage container in which the granule supplement is stored in a lid, the container body is filled with a dispersion medium, and the granule can be mixed with the dispersion medium at the time of taking. A state in which the granule 2 is sealed in a container 3 in which the dispersion medium 1 is stored and a lid 4 having a small storage portion is shown in FIG. The state in which the tip of the blade body 6 provided in the lid body pierces the seal 5 by pushing the lid body 4 and the granule 2 is mixed with the dispersion medium 1 is shown in FIG. (C) shows the cross section of the middle part of the lid 4, and in this example, the blade body 6 has a cross shape, and a device for securing a powder storage space and enlarging the opening of the seal 5 is proposed. Has been.
An example of a bottle container in a state where the granule and the dispersion medium are mixed is shown in FIG.

[Test Example 1]
The present invention will be described in more detail below by preparing beverages and test examples in which granules and a dispersion medium are combined.
<Preparation of dispersion medium>
1. Mixing of dispersion media Nine types of dispersion media were prepared by mixing materials consisting of gellan gum, pectin, psyllium seed gum, dextrin, ph adjuster, gelling aid and water, and adjusting the temperature and stirring. The formulation is as described in Table 1.

2. Preparation of Dispersion Medium (1) In the dispersion medium (b), 0.50 g of a gelling agent was weighed and dissolved by stirring at 80 ° C. for 10 minutes with about 80 g of hot water. After adding 0.05% calcium lactate as a gelling aid, it was adjusted to 100 g and used.
(2) Dispersion media (c) to (f) weighed 0.010 g, (d) 0.025 g, (e) 0.050 g, and (f) 0.075 g, respectively, and 80 g After stirring and dissolving at 90 ° C. or higher for 10 minutes with hot water of a degree, 0.05% calcium lactate was added as a gelling aid and adjusted to 100 g.
(3) Dispersion media (g) to (i) were prepared by weighing 0.10 g, (h) 0.25 g, and (i) 0.50 g of gelling agent (80 g) with about 80 g of hot water, After stirring and dissolving for 10 minutes, 0.05% calcium lactate was added as a gelling aid, and then adjusted to 100 g and used.

<Preparation of granule supplement>
A. Manufacture of raw granules 1) Raw carrot extract raw granules 0.08 kg of ethanol is added to 0.8 kg of ginseng extract, and a triaxial kneading granulator (Triple Master TMGV-5: manufactured by Shinagawa Kogyo Co., Ltd.) is used. Mixed granulated.
Next, 0.012 kg of purified water was added to 0.1499 kg of crystalline cellulose (Theolas UF-F702: manufactured by Asahi Kasei Chemicals), which had been prepared in advance, and the same triaxial kneading granulator (Triple Master TMGV-5: Shinagawa Industries). 0.081 Kg was added, and further granulated, followed by primary drying at 50 ° C. Next, after the particles were crushed, the particles were taken out from the apparatus and dried at 50 ° C. for 12 hours using a blower drying apparatus to reduce the moisture of the granules to 2% or less. The dried granules were sized with a JIS 16 mesh sieve to obtain a uniform particle size, and 1 kg of the original granule was obtained.

2) γ-aminobutyric acid (GABA) raw granule GABA extract (manufactured by Oriza Oil Chemical Co., Ltd.) 0.8 kg and crystalline cellulose (Ceolus FD-F20: manufactured by Asahi Kasei Chemicals Co., Ltd.) 0.2 kg are added with 0.1 kg of ethanol, and Primary granulation was performed using Triple Master TMGV-5. Next, 100 g of 50% ethanol was added to perform secondary granulation, and 0.05 kg of water was further added to perform tertiary granulation, followed by primary drying. Thereafter, the raw granule was taken out from the apparatus, and dried at 50 ° C. for 12 hours using a blowing low-temperature dryer, so that the moisture content of the granule was 2% or less. After the completion of drying, the mixture was sieved with a 16 mesh sieve in the same manner as described above, and the size was adjusted to obtain 1 kg of the original granule.

3) Vitamin C original granules Vitamin C (manufactured by BASF) 0.7639 Kg and water-soluble cellulose powder (Metroses SE-60: Shin-Etsu Chemical Co., Ltd.) 0.0316 Kg were mixed using the triple master TMGV-5. Then, kneading granulation was performed using a solution obtained by dissolving 0.0045 kg of the above water-soluble cellulose in 0.0405 kg of purified water. After granulation, the original granule was dried at 50 ° C. for 12 hours using an air dryer to obtain 0.8 kg of the original granule having a moisture content of 2% or less.

4) Vitamin B raw granule VB mix (manufactured by NOF) 0.8Kg and crystalline cellulose (Theolas FD-F20: manufactured by Asahi Kasei Chemicals) 0.2kg ethanol 0.1kg, the above triple master TMGV-5 After primary granulation by using, primary drying was performed. Thereafter, the raw granule was taken out from the apparatus, and dried at 50 ° C. for 12 hours using a blowing low-temperature dryer, so that the moisture content of the granule was 2% or less. After the completion of drying, the mixture was sieved with a 16 mesh sieve in the same manner as described above, and the size was adjusted to obtain 1 kg of the original granule.

5) Seamless Encapsulating Agent Encapsulating Eicosapentaenoic Acid (EPA) According to the description in WO2009 / 004999, 10 kg gelatin seamless encapsulating agent encapsulating eicosapentaenoic acid having the composition of Example 1 of the publication was obtained.

B. Coating of original granules 1) Coating method 2 parts by mass of polyglycerin fatty acid ester (Poem TR-FB: manufactured by Riken Vitamin Co., Ltd.) is added to 8 parts by mass of the original granules prepared in 1) to 4) above. Coating was performed using Triple Master TMGV-5, which was used when the granules were prepared. In the coating, the temperature in the container was set to a temperature setting (55 ° C.) near the softening point of the polyglycerol fatty acid ester. After cooling, the mixture was sieved using a 16 mesh sieve and sized.

2) Characteristics of coated granules The coated granules thus obtained had a moisture content of 2% or less, and the reactivity with other particles was suppressed by the coating.

C. Mixed Coated GABA granules and vitamin C granules (Example 1), Coated ginseng granules and eicosapentaenoic acid (EPA) -containing seamless capsules (Example 2), Coated vitamin C granules and EPA Combinations of seamless encapsulating agents (Example 3) were used in equal amounts and mixed with a V-type mixer to obtain composite granules.
As the EPA-containing seamless encapsulating agent, 10 kg of gelatin seamless encapsulating agent containing eicosapentaenoic acid having the composition of Example 1 of the same publication was prepared according to the description of WO2009 / 004999.
The coated vitamin B original granule was not used as a composite granule, but was used as it was as a vitamin B granule (Example 4).

<Evaluation of dispersibility>
(1) Dispersion treatment, runoff treatment After filling a glass vial with a diameter of 34 mm with a dispersion medium of (a) to (i) to a height of 50 mm and cooling, 1.7 g of GABA granules and vitamins of Example 1 above The composite granule with C granule was put and mixed by shaking vigorously up and down 10 times. The container was tilted to remove the gel.
(2) Evaluation Evaluation of the mixed state and evaluation of the state of the composite granule remaining in the vial container after taking out the composite granule of GABA granule and vitamin C granule of Example 1 by discharging was performed according to the following criteria. It was.
The evaluation results are shown in Table 2. The mixed body was evaluated for a state immediately after mixing, 5 minutes, 10 minutes, and 15 minutes. This is an evaluation assuming a usage pattern in which powder is dispersed and taken immediately before taking. An example of a mixture is shown in FIG.

a) Evaluation of the mixed state 0: Not dispersed at all in the solution, not mixed 1: Mixed with the solution but precipitated 2: Mixed with the solution and no precipitation 3: Dispersed homogeneously in the solution

b) State evaluation after removal 0: Cannot be taken out even when tilted 1: Although it appears when tilted, there are many remaining 2: When it is tilted, it remains and there is not much remaining

c) Comprehensive evaluation Immediately after mixing, the mixed state evaluation value after 5 minutes, 10 minutes, and 15 minutes and the state evaluation value after removal were summed, and comprehensive evaluation was performed according to the following criteria.
X: 0 to 5 (not different from water or evaluation is lower than water)
(Triangle | delta): 6-9 (it is better than water, but a subject remains)
○: 10 to 14 (very good for solving problems)

<Evaluation of physical properties of dispersion medium>
The physical properties of the dispersion medium were tested for the relationship between shear rate and viscosity. A 3 mm thick gel was prepared on a plastic petri dish having a diameter of 5 cm and used for the test. The portion that protruded from the plate during measurement was removed.
The measurement results are shown in FIG.
(1) Equipment used TA Instruments viscoelasticity measuring device Stress control rheometer AR-G2
(2) Measurement conditions Plate used: 4 cm in diameter Aluminum parallel plate Gap: 2000 μm
Measurement mode: Steady flow viscosity measurement Shear rate: 1.0 × 10 ⁻⁴ s ^{−1 to} 1.0 × 10 ⁻¹ s ⁻¹

5. Results In Table 2, paying attention to (b), (d), and (g), which are comprehensive evaluations “◯”, the physical properties of the dispersion medium were confirmed, and the viscosity at a shear deformation rate of 0.01 s ⁻¹ was obtained. It became clear that the solution which is 10-300 Pa.s was contained. In particular, it can be seen that a gellan gum 0.025 wt% aqueous solution, gellan gum 0.04%, pectin 0.0048 wt% aqueous solution are suitable.

<Preservation test and evaluation of granules>
<Preparation of granule supplements> The granules of Examples 1 to 3 prepared in C are accommodated in the lid of a bottle, and the solution of b described in Table 1 is filled in the bottle, and the temperature is 40 ° C and the humidity is 75%. The sample was placed in the environment for 2 weeks, and changes in composition, appearance, and off-flavor were observed (product of the present invention). Similarly, only the original granules were mixed (Comparative Test Example 1), and the coating was performed without adjusting the water content of the original granules (moisture content of about 5% by mass) (Comparative Test Example 2). -3 granules prepared in advance by stirring and mixing (Comparative Test Example 3) were prepared and the progress was observed daily. The observation results are shown in Table 3 below.

  As is clear from the results shown in Table 3, the product of the present invention did not cause any change in formulation, change in appearance, generation of off-flavor, etc. even after 2 weeks.

<Appearance and taste test when granules are dispersed in dispersion medium>
In a glass vial having a diameter of 24 mm, <Preparation of dispersion medium> 2. The dispersion medium (b) was added to a height of 30 mm, 0.5 g of the vitamin B granule of Example 4 prepared in the above <Preparation of granule supplement> C was added, and mixed by shaking up and down 5 times. Immediately after mixing, appearance, bitterness were evaluated after 5 minutes, 10 minutes, and 15 minutes. After mixing for 5 minutes, 10 minutes and 15 minutes, the mixture was shaken up and down twice before evaluation.
As a comparative example, the vitamin B granule of Example 4 was tested in the same manner using the granule before coating with polyglycerin fatty acid ester.
Appearance evaluation was evaluated according to the following criteria.

A: There is almost no coloring.
○: Colored slightly.
Δ: Colored.
X: It colored deeply.

  The bitterness was evaluated by five panelists specializing in sensory evaluation according to the following criteria. The average value of the evaluation results was rounded off to obtain the evaluation value.

3: Does not feel the bitterness peculiar to vitamins.
2: Slightly feels the bitterness peculiar to vitamins.
1: The bitterness peculiar to a vitamin is considerably felt.
0: I strongly feel the bitterness peculiar to vitamins.

  Table 4 shows the results of appearance evaluation, Table 5 shows the results of bitterness evaluation, and FIG.

  By coating the granule with polyglycerin fatty acid ester, it prevents elution of the component when mixed with the dispersion medium, and prevents the taste of the component from spreading into the solution, so that it does not feel a strange taste when drinking Was confirmed.

[Test Example 2]
Multivitamin granules without coating, which were formulated mainly with the following vitamins, were prepared, and the dispersibility of the combination of granules and dispersion medium was evaluated.

<Preparation of granule supplement>
1. Multivitamin composition
Mixing ratio (wt%)
・ VB mix (NOF Corporation 25.0
・ Carotene (granule) (Kyowa Hakko Kogyo Co., Ltd.) 10.0
・ Vitamin C (NOF Corporation) 55.0
・ Vitamin D3 powder (BASF Japan K.K.) 1.0
D-α tocopherol powder (Eisai Co., Ltd.) 9.0

2. Preparation of granules (1) Equipment used <granulation>
Agitation granulator; high speed mixer
LFS-GS-2J (Fukae Powtech Co., Ltd.)
<Dry>
Fluidized bed granulator: Fluidized bed granulated coating device MP-01
(Powrec Co., Ltd.)

(2) Production Raw materials other than carotene beads were charged into a high speed mixer, 10% of water was added to the raw material weight, and kneading was carried out for 3 minutes at agitator 300 rpm and chopper 3000 rpm.
Thereafter, the kneaded product obtained was dried with a fluidized bed granulator at an air supply temperature of 70 ° C. to obtain granules. The obtained granules and carotene beads were mixed in a plastic bag to prepare multivitamin granules.

(3) Composition of granule particle size A granule preparation having a particle size distribution with the following ratio was produced by measurement with a sieve shaker (manufactured by Tsutsui Richemical Machine Co., Ltd., device name: MICRO VIBRO SIFTER M-2).

Particles exceeding 1.00 mm: 0.3%
0.71-1.00 mm particles: 16.4%,
0.50 to 0.71 mm particles: 21.9%
0.30 to 1.50 mm particles: 40.4%,
0.25 to 0.30 mm particles: 6.6%,
0.18 to 0.25 mm particles: 9.5%,
0.15 to 0/18 mm particles: 2.3%
Particles less than 0.15 mm: 2.6%

(4) Average bulk specific gravity The average bulk specific gravity of the obtained multivitamin granule was 0.57.

3. Evaluation of dispersibility (1) Dispersion treatment, outflow treatment After filling a glass vial with a diameter of 24 mm with a dispersion medium of (a) to (i) to a height of 30 mm and cooling, 0.5 g of the multivitamin granule is added. And vigorously shaken up and down 10 times to mix. The container was tilted to remove the gel.
(2) Evaluation Evaluation of the mixed body and evaluation of the state of the multivitamin granules remaining in the vial container after taking out the discharged multivitamin granule powder were performed according to the following criteria. The evaluation results are shown in Table 6.
The mixed body was evaluated for a state immediately after mixing, 5 minutes, 10 minutes, and 15 minutes. This is an evaluation assuming a usage pattern in which powder is dispersed and taken immediately before taking. An example of the mixed body is shown in FIG.

<Mixed body evaluation>
0: Not dispersed or mixed in the solution 1: Mixed with the solution but precipitated 2: Mixed with the solution and no precipitation 3: Dispersed homogeneously in the solution

<Evaluation of state after removal>
0: Cannot be taken out even if tilted 1: Comes out when tilted, but there is a lot of residual 2: Comes out when tilted, there is not much residual

<Comprehensive evaluation>
X: 0 to 5 (not different from water or evaluation is lower than water)
(Triangle | delta): 6-9 (it is better than water, but a subject remains)
○: 10 to 14 (very good for solving problems)

Claims (5)

A granule whose surface is coated with a polyglycerin fatty acid ester is stored in the lid of the bottle, and the bottle has a viscosity of 10 to 300 Pa · s at a shear deformation rate of 0.01 s ^−1. A bottled drink, which is filled with a solution and is used for drinking after mixing the granule with the solution before drinking. A granule containing drugs or nutritional components that are contraindicated in each other, and the granule whose surface is coated with a polyglycerin fatty acid ester is stored in the lid of the bottle. A bottled drink characterized by being filled with a solution having a viscosity of 10 to 300 Pa · s at a deformation rate of 0.01 s ⁻¹ and mixing the granules with the solution before drinking.   The bottled beverage according to claim 1 or 2, wherein the solution is an aqueous solution containing gellan gum.   The bottled beverage according to claim 1 or 2, wherein the solution is an aqueous solution containing psyllium seed gum and / or pectin and gellan gum.   The bottled beverage according to claim 1, wherein the water content of the granule is 2% by mass or less.